Page 131 - 南京医科大学自然版
P. 131

第44卷第10期                    林赟赟,程 鹏. 2型糖尿病患者脆性骨折风险增加的机制[J].
                 2024年10月                    南京医科大学学报(自然科学版),2024,44(10):1441-1447                      ·1447 ·


                    inhibition of osteoblast like MC3T3 ⁃ E1 differentiation  Today Bio,2023,23:100835
                    promotes mitochondrial perturbations[J]. PLoS One,  [71]WEDELL ⁃ NEERGAARD A S,LANG LEHRSKOV L,

                    2022,17(6):e0270001                                CHRISTENSEN R H,et al. Exercise⁃induced changes in
               [59]SINGH S,SARMA D K,VERMA V,et al. From cells to      visceral adipose tissue mass are regulated by IL⁃6 signal⁃
                    environment:exploring the interplay between factors  ing:a randomized controlled trial[J]. Cell Metab,2019,
                    shaping bone health and disease[J]. Medicina,2023,59  29(4):844-855.e3
                    (9):1546                                     [72]HE B R,YIN X H,HAO D J,et al. Blockade of IL⁃6 allevi⁃
               [60]李晓宇,冯正平. 糖尿病性骨质疏松发病机制的研究进                           ates bone loss induced by modeled microgravity in mice[J].
                    展[J]. 中国骨质疏松杂志,2014,20(5):580-583                  Can J Physiol Pharmacol,2020,98(10):678-683
               [61]SROGA G E,STEPHEN S J,WANG B W,et al. Techniques  [73] SANGUINETI R,MONACELLI F,PARODI A,et al. Vita⁃
                    for advanced glycation end product measurements for  mins D3 and K2 may partially counterbalance the detrimen⁃
                    diabetic bone disease:pitfalls and future directions[J].  tal effects of pentosidine in ex vivo human osteoblasts[J].
                    Curr Opin Endocrinol Diabetes Obes,2022,29(4):333-  J Biol Regul Homeost Agents,2016,30(3):713-726
                    342                                          [74] KITAURA H,OGAWA S,OHORI F,et al. Effects of
               [62]方    语,李凯伟,罗      静,等. 糖尿病性骨质疏松症发病                  incretin ⁃ related diabetes drugs on bone formation and
                    机制研究进展[J]. 四川生理科学杂志,2022,44(7):                    bone resorption[J]. Int J Mol Sci,2021,22(12):6578
                    1310-1313                                    [75] NAUCK M. Incretin therapies :highlighting common
               [63]DHALIWAL R,EWING S K,VASHISHTH D,et al. Greater     features and differences in the modes of action of glucagon⁃
                    carboxy⁃methyl⁃lysine is associated with increased frac⁃  like peptide⁃1 receptor agonists and dipeptidyl peptidase⁃4
                    ture risk in type 2 diabetes[J]. J Bone Miner Res,2022,  inhibitors[J]. Diabetes Obes Metab,2016,18(3):203-216
                    37(2):265-272                                [76]STEGEN S,VAN GASTEL N,CARMELIET G. Bringing
               [64]CAVATI G,PIRROTTA F,MERLOTTI D,et al. Role of       new life to damaged bone:the importance of angiogenesis
                    advanced glycation end⁃products and oxidative stress in  in bone repair and regeneration[J]. Bone,2015,70:19-
                    type⁃2⁃diabetes⁃induced bone fragility and implications  27
                    on fracture risk stratification[J]. Antioxidants,2023,12  [77]MAURICIO D,GRATACÒS M,FRANCH⁃NADAL J. Dia⁃
                    (4):928                                            betic microvascular disease in non ⁃ classical beds:the
               [65]MARCUCCI G,DOMAZETOVIC V,NEDIANI C,et al.           hidden impact beyond the retina,the kidney,and the
                    Oxidative stress and natural antioxidants in osteoporosis:  peripheral nerves[J]. Cardiovasc Diabetol,2023,22(1):
                    novel preventive and therapeutic approaches[J]. Antioxi⁃  314
                    dants,2023,12(2):373                         [78]STABLEY J N,PRISBY R D,BEHNKE B J,et al. Type 2
               [66]LI M S,ZHAO Z H,YI J R. Biomaterials designed to modu⁃  diabetes alters bone and marrow blood flow and vascular
                    late reactive oxygen species for enhanced bone regenera⁃  control mechanisms in the ZDF rat[J]. J Endocrinol,
                    tion in diabetic conditions[J]. J Funct Biomater,2024,15  2015,225(1):47-58
                   (8):220                                       [79]ALMUTLAQ N,NEYMAN A,DIMEGLIO L A. Are diabe⁃
               [67] GUTOWSKA K,CZAJKOWSKI K,KURYŁOWICZ A.              tes microvascular complications risk factors for fragility
                    Receptor for the advanced glycation end products   fracture?[J]. Curr Opin Endocrinol Diabetes Obes,2021,
                    (RAGE)pathway in adipose tissue metabolism[J]. Int J  28(4):354-359
                    Mol Sci,2023,24(13):10982                    [80]SAADI M S S,DAS R,MULLATH ULLAS A,et al. Impact
               [68]FORTE Y S,RENOVATO⁃MARTINS M,BARJA⁃FIDAL⁃           of different anti⁃hyperglycaemic treatments on bone turn⁃
                    GO C. Cellular and molecular mechanisms associating  over markers and bone mineral density in type 2 diabetes
                    obesity to bone loss[J]. Cells,2023,12(4):521      mellitus patients:a systematic review and meta⁃analysis[J].
               [69]LEKKALA S,TAYLOR E A,HUNT H B,et al. Effects of     Int J Mol Sci,2024,25(14):7988
                    diabetes on bone material properties[J]. Curr Osteoporos  [81]熊雪松,余显霞. 2型糖尿病与骨质疏松症相关性研究
                    Rep,2019,17(6):455-464                             进展[J]. 中国骨质疏松杂志,2017,23(1):130-135
               [70]SHENG N,XING F,WANG J,et al. Recent progress in                         [收稿日期] 2024-04-22
                    bone ⁃ repair strategies in diabetic conditions[J]. Mater                   (本文编辑:蒋      莉)
   126   127   128   129   130   131   132   133   134   135   136